Upfront Diagnostics
Cambridge
About Upfront Diagnostics
Upfront Diagnostics has discovered and validated novel blood biomarkers for the detection of stroke patients suffering from a large vessel occlusion. Biomarkers enable faster and more accurate stroke diagnosis which will decrease the time to treatment, reducing disabilities and deaths after a stroke. Upfront Diagnostics owns a family of patents which protects novel biomarkers for stroke detection.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.6M
- Last round: Grant (May 2025)
- Website: upfrontdiagnostics.com
- Phone: +44 (0)1223 782413
Industries & Categories
Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/upfront-diagnostics-61089 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.